Display Settings:

Format

Send to:

Choose Destination
Cancer Gene Ther. 2003 Sep;10(9):649-60.

Gene therapy of hepatocarcinoma: a long way from the concept to the therapeutical impact.

Author information

  • 1Département de thérapie cellulaire et génique, EFS Alpes Méditerranée, Marseille, France.

Abstract

Hepatocellular carcinoma (HCC), the most prevalent histological form of primary liver cancer is one of the most frequent cancer worldwide. This pathology still requires the development of new therapeutical approaches. Gene therapy strategies focusing on the genetic manipulation of accessory cells involved in the immune reaction against cancer cells, or on the direct transduction of tumor cells with transgenes able to "suicide" cancer cells have been largely developed for more than ten years.

PMID:
12944984
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Nature Publishing Group
    Loading ...
    Write to the Help Desk